{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:18:02Z","timestamp":1761862682647},"reference-count":33,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2007,7,6]],"date-time":"2007-07-06T00:00:00Z","timestamp":1183680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J of Small Animal Practice"],"published-print":{"date-parts":[[2007,9]]},"abstract":"<jats:p><jats:bold>Hydroxyurea is a chemotherapeutic agent used to treat hypereosinophilic syndrome, mast cell tumours and many myeloproliferative disorders. It is usually well tolerated; however, reported side effects include myelosuppression and gastrointestinal complications as well as cutaneous toxicity, in very rare cases. We report the unusual appearance of onychomadesis involving several claws on all feet in two canine patients receiving long\u2010term hydroxyurea treatment. The healing of nail lesions required cessation of treatment in one dog and dose reduction in the second animal, supporting a strict relationship between onychopathy and administration of hydroxyurea. The aim of this case report is to increase clinical awareness of dermatological toxicity associated with long\u2010term administration of hydroxyurea.<\/jats:bold><\/jats:p>","DOI":"10.1111\/j.1748-5827.2006.00301.x","type":"journal-article","created":{"date-parts":[[2007,7,7]],"date-time":"2007-07-07T02:04:53Z","timestamp":1183773893000},"page":"514-517","source":"Crossref","is-referenced-by-count":9,"title":["Unusual dermatological toxicity of hydroxyurea in two dogs with spontaneously occurring tumours"],"prefix":"10.1111","volume":"48","author":[{"given":"L.","family":"Marconato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Fileccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,7,6]]},"reference":[{"key":"e_1_2_4_2_1","doi-asserted-by":"publisher","DOI":"10.5326\/15473317-34-3-197"},{"key":"e_1_2_4_3_1","doi-asserted-by":"publisher","DOI":"10.1089\/152581603322286097"},{"key":"e_1_2_4_4_1","first-page":"92","volume-title":"Small Animal Clinical Oncology","author":"Chun R.","year":"2001"},{"key":"e_1_2_4_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00000372-198312000-00013"},{"key":"e_1_2_4_6_1","first-page":"938","article-title":"Hydroxyurea for treatment of meningioma","volume":"88","author":"Cusimano M. D","year":"1998","journal-title":"Journal of Neurosurgery"},{"key":"e_1_2_4_7_1","first-page":"360","article-title":"Essential thrombocythaemia in two dogs","volume":"129","author":"Favier R. P.","year":"2004","journal-title":"Tijdschrift voor Diergeneeskunde"},{"key":"e_1_2_4_8_1","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2460\/javma.1999.214.12.1809","article-title":"Chronic granulocytic leukemia in a dog","volume":"214","author":"Fine D. M.","year":"1999","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_4_9_1","first-page":"720","article-title":"Spinal meningiomas in dogs: 13 cases (1972\u20101987)","volume":"191","author":"Fingeroth J. M.","year":"1987","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_4_10_1","first-page":"929","volume-title":"Schalm\u2019s Veterinary Hematology","author":"Forrester S. D.","year":"2000"},{"key":"e_1_2_4_11_1","first-page":"343","article-title":"Cutaneous ulcerations on hands and heels secondary to long\u2010term hydroxyurea treatment","volume":"14","author":"Friedrich S.","year":"2004","journal-title":"European Journal of Dermatology"},{"key":"e_1_2_4_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/01652176.1998.9694832"},{"key":"e_1_2_4_13_1","doi-asserted-by":"publisher","DOI":"10.5326\/0390355"},{"key":"e_1_2_4_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/9780470752487.ch3"},{"key":"e_1_2_4_15_1","first-page":"223","volume-title":"The Chemotherapy Source Book","author":"Gutheil J. C.","year":"2001"},{"key":"e_1_2_4_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1346-8138.1999.tb03510.x"},{"key":"e_1_2_4_17_1","first-page":"76","volume-title":"Chimioth\u00e9rapie Anticanc\u00e9reuse","author":"Lanore D.","year":"2002"},{"key":"e_1_2_4_18_1","article-title":"Nail changes after chemotherapy","volume":"83","author":"Las Heras G.","year":"1998","journal-title":"Haematologica"},{"key":"e_1_2_4_19_1","first-page":"686","article-title":"Chronic myelogenous leukemia in the dog","volume":"183","author":"Leifer C. E.","year":"1983","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_4_20_1","doi-asserted-by":"publisher","DOI":"10.5326\/15473317-33-4-307"},{"key":"e_1_2_4_21_1","first-page":"376","article-title":"Treatment of basophilic leukemia in a dog","volume":"166","author":"MacEwen E. G.","year":"1975","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_4_22_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.2002.97.2.0341"},{"key":"e_1_2_4_23_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1939-1676.1997.tb00079.x"},{"key":"e_1_2_4_24_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026770624783"},{"key":"e_1_2_4_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-0813.2001.tb10671.x"},{"key":"e_1_2_4_26_1","first-page":"415","article-title":"Diagnosis of canine primary polycythemia and management with hydroxyurea","volume":"180","author":"Peterson M. E.","year":"1982","journal-title":"Journal of the American Veterinary Medical Association"},{"key":"e_1_2_4_27_1","doi-asserted-by":"publisher","DOI":"10.1054\/jocn.2001.1019"},{"key":"e_1_2_4_28_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1997.86.5.0840"},{"key":"e_1_2_4_29_1","doi-asserted-by":"publisher","DOI":"10.3171\/jns.1997.86.5.0845"},{"key":"e_1_2_4_30_1","doi-asserted-by":"publisher","DOI":"10.5326\/15473317-31-3-194"},{"key":"e_1_2_4_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3164.2003.00346.x"},{"key":"e_1_2_4_32_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2230.2001.00782.x"},{"key":"e_1_2_4_33_1","first-page":"194","article-title":"Veterinary cooperative oncology group \u2013 common terminology criteria for adverse events (VCOG\u2010CTCAE) following chemotherapy or biological antineoplastic therapy in dogs and cats v1.0","volume":"2","author":"Veterinary Cooperative Oncology Group","year":"2004","journal-title":"Veterinary and Comparative Oncology"},{"key":"e_1_2_4_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/0165-2427(83)90031-4"}],"container-title":["Journal of Small Animal Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1748-5827.2006.00301.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1748-5827.2006.00301.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T21:03:08Z","timestamp":1708030988000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1748-5827.2006.00301.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,7,6]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["10.1111\/j.1748-5827.2006.00301.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1748-5827.2006.00301.x","archive":["Portico"],"relation":{},"ISSN":["0022-4510","1748-5827"],"issn-type":[{"value":"0022-4510","type":"print"},{"value":"1748-5827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,7,6]]}}}